IGF2BP2 and ovarian carcinoma: The expression of ALKBH5 in distinct subtypes of ovarian cancer cells was also much higher than IGF2BP2, including differentiated, immunoreactive, mesenchymal and proliferative ovarian cancer (Supplementary Fig. 2B).